Per Lenner

10.1k total citations
149 papers, 6.6k citations indexed

About

Per Lenner is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Per Lenner has authored 149 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Oncology, 43 papers in Pathology and Forensic Medicine and 31 papers in Genetics. Recurrent topics in Per Lenner's work include Cancer Risks and Factors (34 papers), Lymphoma Diagnosis and Treatment (25 papers) and Global Cancer Incidence and Screening (21 papers). Per Lenner is often cited by papers focused on Cancer Risks and Factors (34 papers), Lymphoma Diagnosis and Treatment (25 papers) and Global Cancer Incidence and Screening (21 papers). Per Lenner collaborates with scholars based in Sweden, United States and Germany. Per Lenner's co-authors include Göran Hallmans, Kari Hemminki, Rudolf Kaaks, Robert Johansson, Asta Försti, Håkan Jönsson, Erik Lundgren, Joakim Dillner, Pär Stattin and Lennart Hardell and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Diabetes Care.

In The Last Decade

Per Lenner

147 papers receiving 6.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Per Lenner 2.5k 1.8k 1.4k 1.2k 970 149 6.6k
Göran Hallmans 1.5k 0.6× 1.4k 0.8× 875 0.6× 1.0k 0.8× 688 0.7× 76 6.9k
Roni T. Falk 2.4k 1.0× 1.2k 0.7× 743 0.5× 1.3k 1.1× 539 0.6× 132 5.4k
Asta Försti 1.8k 0.7× 2.8k 1.5× 1.6k 1.2× 818 0.7× 1.1k 1.1× 312 6.3k
Federico Canzian 2.3k 0.9× 3.2k 1.8× 1.8k 1.3× 651 0.5× 1.8k 1.8× 147 7.2k
Stig E. Bojesen 1.8k 0.7× 2.4k 1.4× 1.7k 1.2× 840 0.7× 1.2k 1.2× 172 8.3k
Diana Bull 2.6k 1.0× 759 0.4× 711 0.5× 592 0.5× 679 0.7× 49 5.6k
Alan A. Arslan 1.9k 0.7× 1.4k 0.8× 819 0.6× 399 0.3× 664 0.7× 130 6.2k
Jolanta Lissowska 2.1k 0.8× 2.8k 1.6× 1.6k 1.2× 669 0.6× 876 0.9× 143 8.5k
Elisabet Guinó 1.2k 0.5× 1.9k 1.0× 890 0.6× 431 0.4× 788 0.8× 58 4.7k
Lisa A. Boardman 2.4k 1.0× 2.7k 1.5× 2.1k 1.5× 806 0.7× 2.2k 2.3× 148 6.8k

Countries citing papers authored by Per Lenner

Since Specialization
Citations

This map shows the geographic impact of Per Lenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Lenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Lenner more than expected).

Fields of papers citing papers by Per Lenner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Lenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Lenner. The network helps show where Per Lenner may publish in the future.

Co-authorship network of co-authors of Per Lenner

This figure shows the co-authorship network connecting the top 25 collaborators of Per Lenner. A scholar is included among the top collaborators of Per Lenner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Lenner. Per Lenner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomsen, Hauke, Miguel Inácio da Silva Filho, Robert Johansson, et al.. (2015). Inbreeding and homozygosity in breast cancer survival. Scientific Reports. 5(1). 16467–16467. 5 indexed citations
2.
Koskela, Pentti, Tarja Anttila, Tone Bjørge, et al.. (2012). Chlamydia trachomatis infection is a risk factor for cervical cancer. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 2 indexed citations
3.
Peri, Suraj, Ricardo López de Cicco, Julia Santucci-Pereira, et al.. (2012). Defining the genomic signature of the parous breast. BMC Medical Genomics. 5(1). 46–46. 51 indexed citations
4.
Barekati, Zeinab, Ramin Radpour, Qing Lü, et al.. (2012). Methylation signature of lymph node metastases in breast cancer patients. BMC Cancer. 12(1). 244–244. 54 indexed citations
5.
Harlid, Sophia, Ewa Grzybowska, Jórunn E. Eyfjörd, et al.. (2011). Combined effect of low-penetrant SNPs on breast cancer risk. British Journal of Cancer. 106(2). 389–396. 34 indexed citations
6.
Hemminki, Kari, Jianguang Ji, Asta Försti, Jan Sundquist, & Per Lenner. (2008). Concordance of Survival in Family Members With Prostate Cancer. Journal of Clinical Oncology. 26(10). 1705–1709. 50 indexed citations
7.
Ji, Jianguang, Asta Försti, Jan Sundquist, Per Lenner, & Kari Hemminki. (2008). Survival in ovarian cancer patients by histology and family history. Acta Oncologica. 47(6). 1133–1139. 33 indexed citations
8.
Wilkening, Stefan, Björn Tavelin, Federico Canzian, et al.. (2008). Interleukin promoter polymorphisms and prognosis in colorectal cancer. Carcinogenesis. 29(6). 1202–1206. 60 indexed citations
9.
Lei, Haixin, Andreas Brandt, Robert Johansson, et al.. (2008). Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. Carcinogenesis. 29(7). 1394–1399. 129 indexed citations
10.
Försti, Asta, Hetian Lei, Björn Tavelin, et al.. (2007). Polymorphisms in the genes of the urokinase plasminogen activation system in relation to colorectal cancer. Annals of Oncology. 18(12). 1990–1994. 18 indexed citations
11.
Bordás, Pál, et al.. (2006). Survival from invasive breast cancer among interval cases in the mammography screening programmes of northern Sweden. The Breast. 16(1). 47–54. 29 indexed citations
12.
Manjer, Jonas, Robert Johansson, Göran Berglund, et al.. (2003). Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden). Cancer Causes & Control. 14(7). 599–607. 79 indexed citations
13.
Silins, Ilvars, Elisabeth Åvall‐Lundqvist, Amha Tadesse, et al.. (2002). Evaluation of Antibodies to Human Papillomavirus as Prognostic Markers in Cervical Cancer Patients. Gynecologic Oncology. 85(2). 333–338. 30 indexed citations
14.
Glimelius, Bengt, Gunilla Enblad, Anita Gustavsson, et al.. (1996). Treatment of Hodgkin's Disease: The Swedish National Care Programme Experience. Leukemia & lymphoma. 21(1-2). 71–78. 33 indexed citations
15.
Dillner, Joakim, Fredrik Wiklund, Per Lenner, et al.. (1995). Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer. International Journal of Cancer. 60(3). 377–382. 66 indexed citations
16.
Jönsson, Håkan, et al.. (1994). Pap smear screening and changes in cervical cancer mortality in Sweden. International Journal of Gynecology & Obstetrics. 44(3). 267–272. 75 indexed citations
17.
18.
Lenner, Per, Marcus Sjödin, S.-O. Hietala, et al.. (1991). Metastatic Renal Cell Carcinoma Treated with Purified Leukocyte Interferon. Clinical Response in Relation to Tumor DNA Content. Acta Oncologica. 30(6). 713–717. 2 indexed citations
19.
Johansson, Hemming, et al.. (1991). Hodgkin'S Disease in Northern Sweden 1971-1981 I. A Histopathological Reevaluation of 223 Cases. Acta Oncologica. 30(5). 593–596. 8 indexed citations
20.
Lenner, Per, Erik Lundgren, & Lena Damber. (1979). Clinico-Pathologic Correlation in Non-Hodgkin's Lymphoma: III. Biologic significance of a modified Lukes and Collins classification. PubMed. 18(6). 544–553. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Göran Hallmans Breakdown of academic impact, for papers by Roni T. Falk Breakdown of academic impact, for papers by Asta Försti Breakdown of academic impact, for papers by Federico Canzian Breakdown of academic impact, for papers by Stig E. Bojesen Breakdown of academic impact, for papers by Diana Bull Breakdown of academic impact, for papers by Alan A. Arslan Breakdown of academic impact, for papers by Jolanta Lissowska Breakdown of academic impact, for papers by Elisabet Guinó Breakdown of academic impact, for papers by Lisa A. Boardman
Rankless by CCL
2026